BCL2L12 and melanoma: In melanoma, a synonymous c.51C>T (GenBank: NM_001282520.1) (p.Phe17=) mutation in the BCL2L12 (MIM: 610837) oncogene was shown to impair binding of miRNA hsa-miR-671-5p to the BCL2L12 mRNA, leading to BCL2L12 overexpression and cellular resistance to UV-induced apoptosis.10